NAD metabolic therapy in metabolic dysfunction-associated steatotic liver disease: Possible roles of gut microbiota
The metabolic pathway of nicotinamide adenine dinucleotide (NAD) and the interaction between gut microbiota and hostWhen the imbalance of gut microbiota leads to damage to the intestinal barrier, the microbiota or metabolites can translocate to the liver through the gut-liver axis, affecting liver NAD metabolism. On the one hand, the host utilizes amino acids or vitamins from dietary to synthesize NAD and its precursors, and the host derived circulating NAM is one of the main sources of microbial NAD synthesis. On the other hand, the gut microbiota can utilize dietary fiber that the host cannot metabolize to synthesize NAD and supplement the liver’s NAD pool. In summary, exogenous NAD supplements or dietary can promote gut microbiota and host NAD metabolism and their crosstalk, jointly promoting liver NAD pool levels. L-Asp, L-Aspartic acid; Trp, tryptophan; R5P, ribose 5-phosphate; QA, quinolinic acid; NaMN, nicotinic acid mononucleotide; NAAD, nicotinate adenine dinucleotide; NA, niacin; NAM, nicotinamide; NMN, nicotinamide mononucleotide; NR, nicotinamide riboside; ACMS, aminocarboxymuconate semialdehyde decarboxylase. (Created with BioRender.com)